Infusion information display method, information display system and infusion equipment

Abstract

The invention provides an infusion information display method, an information display system and infusion equipment, and relates to the technical field of medical equipment.The method comprises the steps that infusion information, a biological phase target, biological phase information and an electroencephalogram double-frequency index of an infusion device are obtained; and according to a set display rule, displaying the acquired infusion information, the acquired biological phase target, the acquired biological phase information and the acquired electroencephalogram double-frequency index to a first display area of the display equipment. According to the technical scheme, based on the set display rule, the obtained infusion information, the biological phase target, the biological phase information and the electroencephalogram double-frequency index are displayed in the first display area of the display device, so that medical staff can conveniently analyze and obtain the current infusion condition of the infusion object in combination with the displayed information, and the accuracy of the infusion condition of the infusion object is improved. Therefore, infusion control is better carried out, and the infusion effect is improved.

Description

Technical Field

[0001] This application relates to the technical field of medical devices, and particularly to an infusion information display method, an information display system, and an infusion device. Background Art

[0002] Target controlled infusion (TCI) is a technique based on pharmacokinetics, with the drug concentration in plasma or the effect compartment as an indicator. The computer automatically calculates and controls the infusion rate according to the pharmacokinetic model, so as to achieve the required depth of anesthesia, sedation, and analgesia.

[0003] In the prior art, during the infusion process, mainly the staff makes a manual assessment based on personal experience and the current state of the infusion object to determine the current sedation depth of the infusion object, and then uses the current sedation depth as feedback to control the infusion.

[0004] However, the existing method of manually assessing the sedation depth is often inaccurate, prone to inaccurate infusion control, resulting in poor final infusion control effect. Summary of the Invention

[0005] This application provides an infusion information display method, an information display system, and an infusion device, which are used to solve the problem of poor infusion control effect in the prior art.

[0006] In a first aspect, an embodiment of this application provides an infusion information display method, including:

[0007] Obtain the infusion information, biophase target, biophase information, and bispectral index of the infusion device;

[0008] According to the set display rules, display the obtained infusion information, biophase target, biophase information, and bispectral index in the first display area of the display device.

[0009] In a possible design of the first aspect, the display rules are used to define at least one of the display manner, display form, or display layout of the infusion information, biophase target, biophase information, and bispectral index.

[0010] In another possible design of the first aspect, the method further includes:

[0011] Judge whether the value of the obtained bispectral index belongs to the first interval;

[0012] If the value of the bispectral index does not belong to the first interval, output a sedation state prompt message according to the interval to which the bispectral index belongs.

[0013] In yet another possible design of the first aspect, the method further includes:

[0014] Based on the obtained value of the bispectral index of electroencephalogram and the biophase information, if it is determined that the current configuration value of the biophase target needs to be adjusted, a biophase target adjustment prompt message is output.

[0015] In yet another possible design of the first aspect, the method further includes:

[0016] Obtain at least one of target drug information, pharmacokinetic model, and infusion object information;

[0017] Display at least one of the obtained target drug information, pharmacokinetic model, or infusion object information on the display device.

[0018] In yet another possible design of the first aspect, the method further includes:

[0019] Obtain infusion device information and display the infusion device information on the display device.

[0020] In yet another possible design of the first aspect, the method further includes:

[0021] Receive a control instruction;

[0022] Adjust the display information of the display device and / or control the infusion device according to the received control instruction.

[0023] In yet another possible design of the first aspect, the method further includes:

[0024] Display an infusion control area on the display device, and the infusion control area is used to receive control instructions.

[0025] In a second aspect, an embodiment of the present application provides an information display system, which is applied to a central station, a workstation, an infusion device, or a terminal. The information display system includes a processor, and the processor executes the above-mentioned infusion information display method.

[0026] In a third aspect, an embodiment of the present application provides an infusion device, which includes a driving device, a main body housing, a pump door, a touch screen, and a controller;

[0027] The pump door is movably connected to the main body housing; the touch screen is arranged on the pump door, and the driving device and the controller are arranged inside the main body housing;

[0028] The controller executes the following steps:

[0029] Obtain infusion information, biophase target, biophase information, and bispectral index of electroencephalogram;

[0030] According to the set display rules, the obtained infusion information, biophase target, biophase information, and bispectral index are displayed in the first display area of the display device.

[0031] The infusion information display method, information display system, and infusion device provided by the embodiments of the present application display the obtained infusion information, biophase target, biophase information, and bispectral index in the first display area of the display device based on the set display rules, which can facilitate medical staff to analyze the current infusion status of the infusion object in combination with the displayed information, so as to better control the infusion and improve the infusion effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] The drawings herein are incorporated into the specification and constitute a part of this specification, showing embodiments consistent with the present application, and are used together with the specification to explain the principles of the present application;

[0033] Figure 1 It is a schematic structural diagram of the infusion device provided by the embodiments of the present application;

[0034] Figure 2 It is a schematic flowchart of the infusion information display method provided by the embodiments of the present application;

[0035] Figure 3 It is a schematic diagram of the display interface information display provided by the embodiments of the present application;

[0036] Figure 4 It is a schematic diagram of the display form of the bispectral index provided by the embodiments of the present application;

[0037] Figure 5 It is a schematic diagram of the display layout provided by the embodiments of the present application;

[0038] Figure 6 It is a schematic diagram of the display interface of the display device provided by the embodiments of the present application;

[0039] Figure 7 It is a schematic diagram of the detailed parameter interface of the infusion information provided by the embodiments of the present application;

[0040] Figure 8 It is a schematic diagram of the detailed interface of the TCI mode provided by the embodiments of the present application;

[0041] Figure 9 It is a schematic diagram of the parameter setting interface provided by the embodiments of the present application;

[0042] Figure 10 It is a schematic diagram of the adjustment of the interface display information provided by the embodiments of the present application;

[0043] Figure 11 It is a schematic structural diagram of the electronic device provided by the embodiments of the present application.

[0044] Through the above-mentioned accompanying drawings, specific embodiments of the present application have been shown, and will be described in more detail hereinafter. These drawings and the textual description are not intended to limit the scope of the concept of the present application in any way, but to illustrate the concept of the present application to those skilled in the art by reference to specific embodiments. Detailed Description of the Embodiments

[0045] To make the objectives, technical solutions, and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present application. Apparently, the described embodiments are some, but not all, of the embodiments of the present application. All other embodiments obtained by those of ordinary skill in the art based on the embodiments of the present application without creative efforts shall fall within the scope of protection of the present application.

[0046] Target controlled infusion (TCI) is a technology based on pharmacokinetics, with the drug concentration in the plasma or the effect compartment as the index, and the computer automatically calculates and controls the infusion rate according to the pharmacokinetic model to achieve the required depth of anesthesia, sedation, and analgesia. Currently, during the target-controlled infusion process, parameters such as the target concentration, effect compartment concentration, plasma concentration, and current infusion flow rate are mainly displayed, but the sedation depth of the current patient is not known. Without an external anesthesia depth detector, the sedation level of the patient can only be evaluated based on the doctor's experience, the current state of the patient, and the monitoring state, which is relatively limited in guiding anesthesia medication.

[0047] In view of the current problems, the embodiments of the present application provide an infusion information display method, system, and infusion device. By using pharmacokinetic and pharmacodynamic models, the Bispectral Index (BIS) of a wide range of people is obtained. During the infusion process, not only parameters such as infusion information, biophase target, and biophase information are displayed, but also the BIS value of the current patient under the current medication condition is displayed to further assist clinicians in adjusting anesthesia medication to achieve the desired sedation effect.

[0048] Next, the technical solutions of the present application will be described in detail through specific embodiments. It should be noted that the following specific embodiments can be combined with each other, and the same or similar concepts or processes may not be repeated in some embodiments.

[0049] Exemplarily, Figure 1 is a schematic structural diagram of the infusion device provided by the embodiment of the present application, as Figure 1As shown, a pump door 12 is provided on the main body housing 11, and the pump door 12 is movably connected to the main body housing 11. Among them, a touch screen 13 is further provided on the pump door 12, and relevant information (such as infusion information, biophase target, biophase information, and bispectral index) can be displayed on the touch screen 13. In addition, a touch area for medical staff to perform touch operations can be configured on the touch screen 13, and medical staff can adjust the information displayed on the display interface of the display device through touch operations. In addition, a driving device 14 and a controller (not shown) are provided inside the main body housing 11, and the method steps provided in the embodiments of the present application are executed through the controller. Among them, a cavity is formed inside the main body housing 11, and the driving device 14 can extend inward or outward. When the pump door 12 is opened, a drug syringe can be placed in the cavity. The drug syringe contains the drug to be injected. When the driving device 14 extends inward, it will drive the drug syringe in the cavity to inject the drug.

[0050] Figure 2 It is a schematic flowchart of the infusion information display method provided by the embodiments of the present application. This method can be applied to a central station, a workstation, an infusion device, or a terminal through a system integration method. Among them, a display device can be integrated inside the central station, the workstation, the infusion device, or the terminal, or it can be connected to an external display device through a wired interface or a wireless signal, etc. Relevant information is displayed on the display interface of the display device through the steps provided by the embodiments of the present application. As Figure 2 shown, the method can specifically include the following steps:

[0051] Step S201, obtain the infusion information, biophase target, biophase information, and bispectral index of the infusion device.

[0052] In this embodiment, the infusion device may include the above-mentioned Figure 1 shown driving device, main body housing, pump door, touch screen, and controller.

[0053] In this embodiment, the infusion information can reflect the information of the target drug (such as anesthetic, etc.) infused into the infusion object (such as a patient, a sufferer). For example, the infusion information can at least include the infusion speed and / or infusion volume of the target drug. Further, it can also include one or more of the infusion time, infusion mode (such as TCI mentioned above), infusion progress, etc. In addition, when the infusion information is displayed on the display interface of the display device, it can be displayed in numerical form, such as displaying the current value, predicted value, calculated value, historical value; it can also be displayed in the form of a trend graph, such as displaying a schematic diagram of the curve relationship between the value and time. It can also be displayed on the display interface of the display device in the form of a combination of the current value and the trend graph. Of course, the specific display form can be adjusted according to the specific application scenario, and the present application does not make any restrictions.

[0054] In this embodiment, the biophase target is to output the target concentration of the target drug (such as an anesthetic) to the infusion subject, which can be the plasma target concentration or the effect-site target concentration. Among them, the target concentration of the target drug, the plasma target concentration, or the effect-site target concentration can all be preset. For example, specifically, it can be calculated based on one or more of the actual conditions of different infusion subjects (specifically including one or more of the age, gender, height, weight, medical history, etc. of the infusion subject), the target drug to be infused, the relevant infusion parameters configured during the infusion process, etc., in combination with the selected pharmacokinetic model.

[0055] In this embodiment, the biophase information reflects the concentration of the target drug in the infusion subject, and can include the plasma concentration and / or the effect-site concentration. Among them, the biophase information can be detected, for example, detected by a drug concentration detection device, or can be calculated by a pharmacokinetic model. The value of the biophase information can change over time. For example, the concentration of the target drug in the infusion subject can change with the infusion time. In addition, the value of the biophase information can also include one or more of the current value, predicted value, calculated value, and historical value.

[0056] In this embodiment, the bispectral index is used to reflect the depth of sedation of the infusion subject. Specifically, it can be a predicted value or a calculated value derived and calculated through a pharmacokinetic model, or a real-time current value or a historical value detected by a detection instrument. The bispectral index can be one or more of a predicted value, a calculated value, a current value, and a historical value. For example, the value of the bispectral index can be predicted according to the target concentration, patient information (such as one or more of height, weight, age, gender, etc.), drug name, drug concentration, and pharmacokinetic model to calculate the infusion process. Usually, there is a corresponding sedation range interval for the infusion subject. If the value of the bispectral index is within this sedation range interval, it means that the expected sedation state has been achieved. If the value of the bispectral index is not within this sedation range interval, it means that the infusion subject has insufficient sedation or excessive sedation. Specifically, when the value of the bispectral index is higher than this sedation range interval, it means that the infusion subject has insufficient sedation; when the value of the bispectral index is lower than this sedation range interval, it means that the infusion subject has excessive sedation.

[0057] In addition, in this embodiment, it has been mentioned above that this method can be applied to a central station, a workstation, an infusion device, or a terminal. Among them, the infusion information, biophase target, biophase information, and bispectral index can be transmitted to the central station, workstation, infusion device, or terminal in a wired or wireless manner.

[0058] Step S202, according to the set display rules, display the obtained infusion information, biophase target, biophase information, and bispectral index on the first display area of the display device.

[0059] In this embodiment, the display device can be an external device or integrated into a central station, a workstation, an infusion device or a terminal. Among them, the display device can display the infusion information, biophase target, biophase information and bispectral index obtained by the central station, workstation, infusion device or terminal in the first display area of its display interface.

[0060] In this embodiment, the first display area can be any one or more of the middle area, left area, right area, top area and bottom area of the display interface. Exemplarily, Figure 3 is a schematic diagram of the display interface information provided by the embodiment of the present application. As Figure 3 shown, the middle area 31 of the display interface can be used as the first display area.

[0061] In addition to the first display area of the display interface, there can also be a second display area, a third display area,..., an Nth display area, and these display areas can display other information other than the infusion information, biophase target, biophase information and bispectral index (for example, in Figure 3 the second display area 32 can display the device information of the infusion device itself (such as the current power and current time), and in Figure 3 the third display area 33 in it displays the control information for controlling the infusion device (such as virtual touch buttons for controlling the infusion device (start fast forward button 331, pause fast forward button 332), etc.).

[0062] In this embodiment, the display rule can be a preset default rule or associated with medical staff. For example, different medical staff can configure different display rules. In addition, the display rule can also be associated with one or more of the usage scenario, usage department, infusion mode, etc. According to different usage scenarios, usage departments or infusion modes, set the information presentation method and / or layout that conforms to the usage habits of medical staff. When there are multiple display rules stored, different deployment orders can also be set for different display rules. For example, when the infusion device needs to display the infusion information, biophase target, biophase information and bispectral index, the display rule configured by the medical staff can be preferentially retrieved. If the display rule configured by the medical staff is not found in the rule library, then based on the default rule, the infusion information, biophase target, biophase information and bispectral index can be displayed in the first display area of the display device.

[0063] Among them, the main purpose of setting the display rules is to enable medical staff to read this information more intuitively and quickly from the display interface. Based on the viewing habits of different medical staff for the display interface, for example, the information that medical staff using the central station need to pay attention to is different from that of medical staff using workstations, infusion devices, or terminals. Therefore, different display rules can be configured for different application scenarios, etc.

[0064] In addition, according to the specific usage scenario, one or more pieces of information can also be selected from the obtained infusion information, biophase target, biophase information, and bispectral index, and then the selected information can be displayed in the first display area. For example, the infusion device can only select the infusion information, biophase target, and biophase information to be displayed in the first display area, while the bispectral index is not displayed in the first display area.

[0065] In the embodiment of the present application, based on the set display rules, the obtained infusion information, biophase target, biophase information, and bispectral index are displayed in the first display area of the display device, which can facilitate medical staff to analyze the current infusion status of the infusion object in combination with the displayed information, so as to better control the infusion or monitor the patient and improve the infusion effect.

[0066] Specifically, the display rules can define at least one of the display method, display form, or display layout of the infusion information, biophase target, biophase information, and bispectral index.

[0067] In this embodiment, the display method may refer to the specific content of the displayed information. For example, the specific content may include the current value, historical value, predicted value, actual measurement value, and so on.

[0068] In this embodiment, the display form may refer to the presentation form of the displayed information on the display interface. For example, it may be in text form, digital form, table form, or curve form. Exemplarily, Figure 4 is a schematic diagram of the display form of the bispectral index provided by the embodiment of the present application. As Figure 4 shown, the bispectral index can be displayed in numerical form in the first display area 31, or can be displayed in curve form in the first display area 31.

[0069] In this embodiment, the display layout may refer to the display position and layout of the displayed information. For example, in the first display area, where are the specific display positions of the infusion information, biophase target, biophase information, and bispectral index, and how to perform the layout when displaying the infusion information. Exemplarily, Figure 5 is a schematic diagram of the display layout provided by the embodiment of the present application. As Figure 5As shown, the first display area on the display interface can respectively layout and display the drug name, flow rate, bispectral index prediction value, plasma target concentration Cpt, anesthetic concentration Cp in plasma, effect compartment concentration Ce, infusion mode, etc. Additionally, the third display area, the second display area, and the first display area on the display interface can at least partially overlap, intersect, be transparent, or be tiled.

[0070] In this embodiment, the display rules can also define the display effects of infusion information, biophase target, biophase information, and bispectral index, such as defining the font size, font color, and background color of the infusion information, biophase target, biophase information, and bispectral index.

[0071] By defining the display method, display form, or display layout of the infusion information, biophase target, biophase information, and bispectral index in the embodiments of the present application, the information presentation method of the display interface can be made more flexible and variable, adapting to the requirements of different usage scenarios and facilitating the information access of medical staff.

[0072] In some other embodiments, the above infusion information display method may further include the following steps: determining whether the value of the obtained bispectral index belongs to the first interval; if the value of the bispectral index does not belong to the first interval, output a sedation status prompt message according to the interval to which the bispectral index belongs.

[0073] In this embodiment, the first interval refers to the value interval of the bispectral index when the infusion object is in a sedated state. If the value of the obtained bispectral index (which can be a calculated value, a predicted value, an actually detected value, etc.) is not within the first interval, it means that the infusion object is not currently in a sedated state, and it may be necessary to increase or decrease the drug injection amount.

[0074] Among them, the sedation status prompt message can be in text form, voice form, or light and sound form. For example, taking the text form as an example, the text "not in a sedated state" or "excessive sedation" or "insufficient sedation" can be directly displayed on the display interface to prompt medical staff.

[0075] Additionally, in order to improve the prompt effect, it can be further detected whether the value of the obtained bispectral index is higher or lower than the first interval, and different prompts are output according to the high - low position relationship between the value of the obtained bispectral index and the first interval. Specifically, when it is higher than the first interval, the corresponding first sedation status prompt message (indicating insufficient sedation) is output, and when it is lower than the first interval, the corresponding second sedation status prompt message (indicating excessive sedation) is output.

[0076] For example, the first interval can be [40, 60]. If the value of the bispectral index is higher than 60, it indicates that the infusion subject is insufficiently sedated and the injection volume of the drug may need to be increased. If the value of the bispectral index is lower than 40, it indicates that the infusion subject is oversedated and the drug injection may need to be stopped or the injection volume reduced.

[0077] In addition, to ensure that the infusion subject is in a better sedated state, such as during surgery, a BIS value of generally 40 - 60 is a more appropriate sedated state. If the obtained BIS value is lower than 40 or higher than 60, the monitoring information of the infusion subject's monitor (such as heart rate) can be combined to comprehensively judge the depth of sedation and give a reminder of insufficient sedation or oversedation.

[0078] By outputting a sedation state reminder in the embodiments of the present application, the medical staff can be reminded of the current sedation state of the infusion subject, enabling the medical staff to understand the current sedation state of the infusion subject based on the reminder information and perform infusion control based on the current sedation state of the infusion subject, which can further improve the infusion control effect.

[0079] In some other embodiments, the biophase target reflects the target concentration of the target drug to be output to the infusion subject. The biophase target is preconfigured before infusion (for example, specifically calculated in advance based on the actual conditions of different infusion subjects, the target drug to be infused, relevant infusion parameters configured during infusion, etc. as the input of the pharmacokinetic model). The biophase targets configured for different infusion subjects may be different. During actual infusion, the biophase target can be adjusted in real time. For example, if it is determined that the current configured value of the biophase target needs to be adjusted according to the obtained value of the bispectral index and the biophase information, a biophase target adjustment reminder message is output.

[0080] In this embodiment, the biophase information reflects the concentration of the target drug in the current body of the infusion subject, and the value of the bispectral index reflects the current sedation state of the infusion subject. Among them, when the value of the bispectral index is within the first interval mentioned above, it indicates that the infusion subject is currently in a sedated state. At this time, if the concentration of the target drug in the current body of the infusion subject has not reached the target concentration reflected by the biophase target, it indicates that the target concentration is set too high, and at this time, a biophase target adjustment reminder message can be output. Or if the value of the bispectral index is less than the first interval, but the concentration of the target drug in the current body of the infusion subject has reached the target concentration reflected by the biophase target, it indicates that the target concentration is set too high, and at this time, a biophase target adjustment reminder message can also be output.

[0081] Among them, the biophase target adjustment reminder message is divided into two types. One is to remind the medical staff to lower the target concentration reflected by the biophase target, and the other is to remind the medical staff to increase the target concentration reflected by the biophase target.

[0082] Among them, the biophase target adjustment prompt information can be in the form of text, or in the form of sound, or in the form of sound and light. For example, taking the text form as an example, the text "Increase the biophase target" can be directly displayed on the display interface to prompt medical staff.

[0083] In addition, in some other scenarios, if the value of the bispectral index is in the first interval mentioned above, and at the same time the concentration of the target drug in the current body of the infusion object exactly reaches the target concentration reflected by the biophase target, it means that the pre-configured biophase target is exactly suitable for the infusion object. At this time, the biophase target prompt information can also be output to prompt medical staff that there is no need to adjust the biophase target, or it can also prompt medical staff that the target has been reached, etc.

[0084] By outputting the biophase target adjustment prompt information in the embodiments of the present application, it can prompt medical staff whether the current biophase target is reasonably configured. At the same time, if the biophase target is not reasonably configured, it can also inform medical staff whether to continue to increase or decrease the biophase target. In this way, it is convenient for medical staff to perform infusion control and further improve the infusion effect.

[0085] In some other embodiments, in addition to displaying the above-mentioned infusion information, biophase target, biophase information, and bispectral index, at least one of the target drug information, pharmacokinetic model, or infusion object information can also be displayed in the display interface through the fourth display area.

[0086] Among them, the target drug information includes at least one of the target drug name and drug concentration. The infusion object information includes the age, gender, height, weight, and physical condition of the infusion object. The infusion object information can be manually input into the infusion device, or the infusion device can obtain it by networking with other information collection devices through wireless or wired means, etc.

[0087] Among them, when displaying at least one of the target drug information, pharmacokinetic model, or infusion object information, a display strategy can also be configured. The display strategy can define at least one of the display method, display form, or display layout of the target drug information, pharmacokinetic model, or infusion object information.

[0088] In this embodiment, the display method can refer to the specific content of the displayed information. For example, it can display the Chinese name, English name of the target drug, the current value, historical value, predicted value, real-time measurement value, etc. of the drug concentration.

[0089] In this embodiment, the display form can refer to the presentation form of the displayed information on the display interface. For example, it can be in the form of text, or in the form of numbers, or in the form of a table, or in the form of a curve.

[0090] In this embodiment, the display layout may refer to the display positions and typesetting layouts of the displayed information. For example, in the fourth display area, where are the specific display positions of the target drug information, pharmacokinetic model, or infusion object information, and how is the typesetting layout performed when displaying the infusion information, etc. Exemplarily, multiple different display areas (such as the first display area, the second display area, the third display area, and the fourth display area) may be configured on the display interface. For example, continuing to refer to the above Figure 5 , the fourth display area 34 may be configured on the display interface to display the drug name, pharmacokinetic model, and drug concentration. Additionally, the first display area, the second display area, the third display area, and the fourth display area may at least partially overlap, intersect, be transparent, or be tiled.

[0091] In this embodiment, at least one of the target drug information, pharmacokinetic model, or infusion object information may be displayed on the same interface as the above-mentioned infusion information, biophase target, biophase information, and bispectral index. For example, referring to the above Figure 5 , the infusion information, biophase target, biophase information, and bispectral index are displayed in the first display area of the interface, and at least one of the target drug information, pharmacokinetic model, or infusion object information is displayed in the fourth display area of this interface. Another example is that at least one of the target drug information, pharmacokinetic model, or infusion object information may be inserted into the first display area and displayed in the first display area together with the above-mentioned infusion information, biophase target, biophase information, and bispectral index.

[0092] Among them, the interface on which the infusion information, biophase target, biophase information, and bispectral index are displayed may be the main interface of the display device, that is, the interface presented after the display device is powered on and started, or it may be an interface configured by medical staff.

[0093] Exemplarily, continuing to refer to the above Figure 5 , the drug name, pharmacokinetic model, and drug concentration may be on the same interface as the infusion information (including Figure 5 the infusion mode and flow rate therein), the value of the bispectral index, the biophase target (such as Figure 5 the plasma target concentration Cpt therein), and the biophase information (such as Figure 5 the anesthetic concentration Cp in the plasma therein) for display.

[0094] Further, it is also possible to trigger a layout adjustment strategy according to a layout adjustment instruction input by medical staff, for example, it can be input through button operations or other methods such as control instructions transmitted wirelessly. Among them, the layout adjustment strategy is mainly used to adjust the display position of at least one of the above-mentioned target drug information, pharmacokinetic model, or infusion object information. For example, when at least one of the target drug information, pharmacokinetic model, or infusion object information is displayed in the fourth display area of the display interface, the medical staff can input a layout adjustment instruction to adjust at least one of the target drug information, pharmacokinetic model, or infusion object information displayed in the fourth display area to be displayed in the third display area.

[0095] In addition, at least one of the target drug information, pharmacokinetic model, or infusion object information can also be displayed on other interfaces, that is, not on the same interface as the above-mentioned infusion information, biophase target, biophase information, and bispectral index. Exemplarily, Figure 6 is a schematic diagram of the display interface of the display device provided by the embodiment of the present application, as Figure 6 shown, a plurality of operable buttons 63 (i.e., button 1, button 2, and button 3) are configured on the display device 62, and there is also a display interface 61. At this time, infusion object information (i.e., patient information, including one or more of height, gender, weight, age, and gestational age, etc.) and a touch operation area 64 (including a "return" touch operation area and a "next step" touch operation area) can be displayed on the display interface 61. The infusion object information is not displayed on the same interface as the above-mentioned infusion information, biophase target, biophase information, and bispectral index, mainly considering that too much information may not be accommodated on one interface. Therefore, the most important infusion information, biophase target, biophase information, and bispectral index are displayed on the important interface of the display device (for example, it can be the main interface), while at least one of the secondary target drug information, pharmacokinetic model, or infusion object information is displayed on other interfaces.

[0096] It should be noted that if the infusion object information is not displayed on the same interface as the above-mentioned infusion information, biophase target, biophase information, and bispectral index, then a touch operation area (such as "interface switching") can be configured on the main interface for displaying the above-mentioned infusion information, biophase target, biophase information, and bispectral index. When the medical staff clicks "interface switching", they can directly jump to the sub-interface on which at least one of the target drug information, pharmacokinetic model, or infusion object information is displayed.

[0097] By obtaining at least one of the target drug information, pharmacokinetic model, and infusion object information and displaying it on the interface in the embodiment of the present application, it can provide a reference for medical staff, enabling medical staff to more accurately understand the current infusion status, so as to better perform infusion for the infusion object and further improve the infusion effect.

[0098] In some other embodiments, infusion device information may also be displayed on the interface. The infusion device information may include basic information of the infusion device, operating status, etc. Among them, the basic information may include the identifier of the infusion device, the current time, the location, and the operating status may include the operating duration, the power-on duration, and the current battery level.

[0099] In this embodiment, the infusion device information may be displayed on the display interface in the form of text, numerical values, icons, or curves. Among them, when the infusion device information and the above-mentioned other information (such as at least one of the target drug information, pharmacokinetic model, infusion object information, infusion information, biophase target, biophase information, and bispectral index) are displayed on the same interface, a fifth display area may be configured on the display interface to display the infusion device information.

[0100] In addition, the first display area, the second display area, the third display area, the fourth display area, and the fifth display area may at least partially overlap, be transparent, or be tiled.

[0101] In addition, in this embodiment, when the infusion device information and the above-mentioned other information (such as at least one of the target drug information, pharmacokinetic model, infusion object information, infusion information, biophase target, biophase information, and bispectral index) are displayed on the same interface, if the infusion information, biophase target, biophase information, and bispectral index are displayed in the first display area, and at least one of the target drug information, pharmacokinetic model, and infusion object information is displayed in the fourth display area, then the infusion device information may be inserted and displayed in the first display area, may also be inserted and displayed in the second display area, may also be inserted and displayed in the third display area, and may also be inserted and displayed in the fourth display area.

[0102] Exemplarily, reference may continue to be made to the above Figure 5 , the drug name, pharmacokinetic model, and drug concentration may be on the same interface as the infusion information (including Figure 5 the infusion mode and flow rate therein), the value of the bispectral index, the biophase target (such as Figure 5 the plasma target concentration Cpt therein), and the biophase information (such as Figure 5 the anesthetic concentration Cp in the plasma therein). Meanwhile, the infusion device information may be displayed in the second display area 32 on the left side of the interface, such as the time being 13.54 and the current battery level being 80%.

[0103] In addition, the infusion device information can be displayed separately on an interface, that is, not displayed on the same interface as the above other information (such as at least one of the target drug information, pharmacokinetic model, infusion object information, infusion information, biophase target, biophase information, and bispectral index).

[0104] By displaying the infusion device information in the embodiments of the present application, it is also possible to facilitate medical staff to understand the situation of the infusion device in real time, enabling them to determine how to perform infusion for the infusion object in combination with the situation of the infusion device, which can further improve the infusion effect.

[0105] In some other embodiments, the display information of the display device and / or the infusion device can also be adjusted according to the received control instruction.

[0106] In this embodiment, the control instruction can be generated when a medical staff touches certain areas of the display interface, or can be generated when the medical staff operates on the physical buttons of the infusion device, or can also be generated when the medical staff operates other devices, and the other devices transmit it to the infusion device through wireless networking.

[0107] Among them, after the infusion device receives the control instruction, the current display information of the display device can be adjusted. Exemplarily, when the infusion information is displayed in the first display area of the display interface, if the medical staff wants to view more detailed and specific information, a control instruction can be issued (such as directly touching the display area of the infusion information on the display interface, or pressing the physical button of the infusion device to generate a control instruction). At this time, the display interface can be switched to the detailed parameter interface of the infusion information to display more detailed and specific information. Exemplarily, Figure 7 Schematic diagram of the detailed parameter interface of the infusion information provided by the embodiments of the present application, as Figure 7 shown, after receiving the control instruction, the display device can be adjusted to switch to the detailed parameter interface 70 of the infusion information, and detailed and specific information such as induction flow rate, induction dose, induction time, awakening concentration, equilibrium time, running time, flow rate, and cumulative amount can be displayed in the sixth display area 71 on the detailed parameter interface 70 of the infusion information. In addition, a touch control area 72 can be configured on the detailed parameter interface 70 of the infusion information, which includes virtual touch buttons "Switch View" and "Return". The medical staff can touch the virtual touch buttons in the touch control area 72 to achieve interface jump.

[0108] In this embodiment, there are various different ways to generate the control instruction, and the functions implemented by different control instructions can also be different. For example, different control instructions correspond to adjusting different display information. Exemplarily, Figure 8 Schematic diagram of the detailed interface of the TCI mode provided by the embodiments of the present application, as Figure 8As shown, when receiving another control instruction (such as a direct touch Figure 5 the infusion mode in the first display area 31 of the display interface in Figure 5 to generate a control instruction), the display device can be adjusted to switch to Figure 8 the detailed TCI mode interface 80 shown in Figure 8 . Detailed information can be displayed in the seventh display area 81 of the detailed TCI mode interface 80, such as drug name: Drug A, concentration: 10 mg / ml, pharmacokinetic model: Model Y, target control method: plasma target control. Further, a touch control area 82 can also be configured on the detailed TCI mode interface 80, which includes virtual touch buttons "Return" and "Next". Medical staff can touch the virtual touch buttons in the touch control area 82 to achieve interface jumping.

[0109] Further, Figure 9 is a schematic diagram of the parameter setting interface provided by the embodiment of the present application. As Figure 9 shown, when receiving a control instruction for parameter setting (for example, when medical staff wants to set parameters, they can generate a control instruction by pressing the button 63 on the infusion device), based on this control instruction, the display device can be adjusted to switch to the parameter setting control interface 90. Detailed setting information is displayed in the eighth display area 91 of the parameter setting control interface 90, such as target concentration, maximum infusion speed, induction dose, induction pre-set amount, and induction time. Further, a touch control area 92 can also be configured on the parameter setting control interface 90, which includes virtual touch buttons "Return" and "Start". Medical staff can touch the virtual touch buttons in the touch control area 92 to achieve interface jumping.

[0110] In this embodiment, in addition to controlling the display device to switch interfaces, the control instruction can also adjust the display information on the display interface. For example, referring to the above Figure 5 , the flow rate and bispectral index prediction value are displayed in the first display area 31 of the display interface. When receiving a control instruction for adjusting the display information, the flow rate can be replaced with the infusion time, and the bispectral index prediction value can be replaced with the cumulative amount. Exemplarily, Figure 10 is a schematic diagram of adjusting the display information of the interface provided by the embodiment of the present application. As Figure 10 shown, compared with the above Figure 5 , after receiving a control instruction (for example, medical staff can adjust the layout of the information displayed in Figure 5 , generate a control instruction and transmit it to the infusion device wirelessly), Figure 5 the originally displayed flow rate and bispectral index prediction value in Figure 5 are replaced with Figure 10 the infusion time and cumulative amount in Figure 10 .

[0111] In this embodiment, the control instruction can be generated through the above-mentioned Figure 8 , Figure 9 by the buttons 63 (button 1, button 2, and button 3) on the display device, or by configuring virtual buttons that can be touched on the display interface. Medical staff can touch these virtual buttons to generate the above-mentioned control instructions as well. Of course, the control instruction can also be sent by a third-party device such as a central station, a workstation, or a terminal.

[0112] In some other embodiments, an infusion control area can also be displayed on the display device, and the infusion control area is used to receive control instructions.

[0113] In this embodiment, in addition to configuring virtual buttons that can be touched on the display interface, an infusion control area can also be configured. The infusion control area can be displayed on the same interface as at least one of the above-mentioned infusion information, biophase target, biophase information, bispectral index, target drug information, pharmacokinetic model, and infusion object information. For example, a ninth display area can be separately divided on the display interface to display the infusion control area (such as Figure 3 the third display area 33), or the infusion control area can be inserted into the above-mentioned first display area, second display area,..., Nth display area, etc. Of course, an interface can also be separately configured to display the infusion control area.

[0114] Among them, the infusion control area can be in the form of a pattern, in the form of text, or in the form of a combination of a pattern and text. Exemplarily, referring to the above Figure 5 A third display area 33 can be separately divided on the right side of the display interface to display the start fast-forward button 331 and the pause fast-forward button 332 as the infusion control area. Medical staff can perform actions such as clicking and touching in the infusion control area to generate the above-mentioned control instructions. When the medical staff clicks "Start Fast-Forward", the infusion device will accelerate the infusion. When the infusion staff clicks "Pause Fast-Forward", the infusion device will pause the accelerated infusion.

[0115] Furthermore, referring to the above Figure 6 , two infusion control areas, "Return" and "Next Step", are configured in the touch operation area 64 on the right side of the display interface. When the medical staff clicks "Return", it will jump back to the previous interface. When the medical staff clicks "Next Step", it will jump to the next interface.

[0116] By configuring the infusion control area in the embodiment of the present application, control instructions can be received, and at the same time, the display information of the display device and / or the infusion device can be adjusted based on the control instructions, which is convenient for medical staff to perform operation control.

[0117] The embodiment of the present application further provides a pharmacokinetic model BIS prediction system, which includes five modules: a patient information management module, an infusion parameter setting module, a BIS parameter prediction module, a BIS parameter display module, and a patient sedation state monitoring and reminder module. Among them, the patient information management module includes manually editing or automatically obtaining patient information, and the patient information includes: patient name, gender, age, height, weight and other information. The infusion parameter setting module includes the selection and setting of drug name, concentration, pharmacokinetic model, target control mode, and target concentration setting. The BIS parameter prediction module calculates the predicted BIS parameters based on the input patient information and infusion parameters. The BIS parameter display module is used to display parameters such as target concentration, plasma concentration, effect site concentration, infused volume / dose, flow rate / dose rate, and predicted BIS value during the infusion process. The patient sedation state monitoring and reminder module is used to give reminders. Specifically, under normal circumstances, in order to ensure that the patient is in a better sedation state, such as during surgery, a BIS value of generally 40-60 is a more appropriate sedation state. If the predicted BIS value is lower than 40 or higher than 60, combined with the monitoring information of the patient's monitor, a comprehensive judgment of the sedation depth is made, and a reminder of insufficient sedation or excessive sedation is given.

[0118] The pharmacokinetic model BIS prediction system provided by the embodiment of the present application can predict the bispectral index (BIS) of a wide range of populations and is applicable to TCI applications. During the infusion process, it not only displays parameters such as target concentration, effect site concentration, plasma concentration, and current infusion flow rate, but also displays the predicted BIS value of the current patient under the current medication condition, so as to further assist clinicians in adjusting anesthetic medications to achieve the desired sedation effect.

[0119] Figure 11 It is a schematic structural diagram of the electronic device provided by the embodiment of the present application. As Figure 11 shown, the electronic device 1100 includes: at least one processor 1101, a memory 1102, a bus 1103, and a communication interface 1104.

[0120] Among them, the processor, communication interface, and memory communicate with each other through a bus. The communication interface is used to communicate with other devices. The communication interface includes a communication interface for data transmission and a display interface or an operation interface for human-computer interaction, etc. The processor is used to execute the computer instructions stored in the memory and can specifically execute the relevant steps in the methods described in the above embodiments. The processor may be a central processing unit, or a specific integrated circuit (Application Specific Integrated Circuit, ASIC), or one or more integrated circuits configured to implement the embodiments of the present invention. One or more processors included in the electronic device may be of the same type of processor, such as one or more CPUs; or may be of different types of processors, such as one or more CPUs and one or more ASICs. The memory is used to store computer instructions. The memory may include high-speed RAM memory and may also include non-volatile memory, such as at least one disk memory.

[0121] An embodiment of the present application further provides an information display system, which can be integrated in a central station, a workstation, an infusion device or a terminal. The information display system includes a processor, and the processor executes the above-mentioned infusion information display method.

[0122] In the present application, "at least one" means one or more, and "a plurality" means two or more. "And / or" describes the association relationship of associated objects and indicates that three relationships may exist. For example, A and / or B may represent: A exists alone, A and B exist simultaneously, and B exists alone, where A and B may be singular or plural. The character " / " generally represents an "or" relationship between the associated objects before and after; in a formula, the character " / " represents a "division" relationship between the associated objects before and after. "At least one (item)" or a similar expression thereof refers to any combination of these items, including any combination of single item (item) or plural items (items). For example, at least one (item) of a, b, or c may represent: a, b, c, a - b, a - c, b - c, or a - b - c, where a, b, c may be single or multiple.

[0123] It can be understood that the various numerical numbers involved in the embodiments of the present application are only for the convenience of description and are not used to limit the scope of the embodiments of the present application. In the embodiments of the present application, the magnitudes of the serial numbers of the above processes do not mean the order of execution. The execution order of each process should be determined according to its function and internal logic, and should not constitute any limitation to the implementation process of the embodiments of the present application.

[0124] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit them; although the present application has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that they can still modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements on some or all of the technical features; and these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present application.

Claims

1. An infusion information display method, characterized in that, Comprising: Obtaining infusion information, a biophase target, biophase information, and a bispectral index of an infusion device; According to the set display rules, displaying the obtained infusion information, biophase target, biophase information, and bispectral index to a first display area of a display device.

2. The method according to claim 1, characterized in that, The display rules are used to define at least one of a display manner, a display form, or a display layout of the infusion information, biophase target, biophase information, and bispectral index.

3. The method according to claim 1, wherein The method further comprises: Judging whether the value of the obtained bispectral index belongs to a first interval; If the value of the bispectral index does not belong to the first interval, outputting a sedation state prompt message according to the interval to which the bispectral index belongs.

4. The method according to claim 1, wherein The method further comprises: According to the value of the obtained bispectral index and the biophase information, judging that the current configuration value of the biophase target needs to be adjusted, and outputting a biophase target adjustment prompt message.

5. The method according to claim 1, wherein The method further comprises: Obtaining at least one of target drug information, a pharmacokinetic model, and infusion object information; Displaying at least one of the obtained target drug information, pharmacokinetic model, or infusion object information to the display device.

6. The method according to any one of claims 1 to 5, characterized in that The method further comprises: Obtaining infusion device information and displaying the infusion device information to the display device.

7. The method according to any one of claims 1-5, characterized in that, The method further comprises: Receiving a control instruction; Adjusting the display information of the display device and / or controlling the infusion device according to the received control instruction.

8. An information display system, characterized in that, Applied to a central station, a workstation, an infusion device, or a terminal, the information display system comprises a processor, and the processor executes the infusion information display method according to any one of claims 1-7.

9. An infusion device, characterized in that, Including a driving device, a main body housing, a pump door, a touch screen, and a controller; The pump door is movably connected to the main body housing; the touch screen is arranged on the pump door, and the driving device and the controller are arranged inside the main body housing; The controller executes the method according to any one of claims 1-7.

10. The device according to claim 9, characterized in that, A cavity is arranged inside the main body housing, and a drug syringe is accommodated in the cavity. The driving device is used to drive the drug syringe to infuse a target drug into an infusion object.

Images